# Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

> **NCT04353336** · PHASE2,PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 194 (actual)

## Conditions studied

- COVID-19
- Coronavirus Infection

## Interventions

- **DRUG:** Chloroquine or Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04353336
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-23
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353336, "Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04353336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*